- Conditions
- Psoriasis Vulgaris
- Interventions
- Calcipotriol plus betamethasone, Betamethasone-17,21-dipropionate, Calcipotriene, Topical suspension vehicle
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,152 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 59
- States / cities
- Mobile, Alabama • Hot Springs, Arkansas • Anaheim, California + 50 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 63
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Psoriasis Vulgaris
- Interventions
- MC2-01 cream, Cal/BDP combination, Cream vehicle
- Drug
- Lead sponsor
- MC2 Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 794 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 3
- States / cities
- Detroit, Michigan • Fridley, Minnesota • Spokane, Washington
- Conditions
- Plaque Psoriasis, Psoriasis
- Interventions
- Enstilar® foam, Vehicle foam
- Drug
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Psoriasis Vulgaris
- Interventions
- Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%, Enstilar® foam (LEO Pharma Inc.), Placebo of Calcipotriene/ betamethasone dipropionate topical foam
- Drug · Other
- Lead sponsor
- Glenmark Pharmaceuticals Ltd. India
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 494 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2020
- U.S. locations
- 30
- States / cities
- Encinitas, California • Fountain Valley, California • San Diego, California + 24 more
- Conditions
- Pruritus, Psoriasis
- Interventions
- SNA-120, Placebo, Calcipotriene
- Drug
- Lead sponsor
- Sienna Biopharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 73 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 17
- States / cities
- Anniston, Alabama • Mobile, Alabama • Fountain Valley, California + 14 more
- Conditions
- Psoriasis
- Interventions
- Ruxolitinib phosphate cream, Dovonex® calcipotriene 0.005%, Diprolene® AF betamethasone dipropionate 0.05% cream., Placebo cream
- Drug
- Lead sponsor
- Incyte Corporation
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 6
- States / cities
- Vallejo, California • Boston, Massachusetts • Rochester, New York + 3 more
- Conditions
- Psoriasis
- Interventions
- Calcipotriene 0.005% Foam
- Drug
- Lead sponsor
- Mayne Pharma International Pty Ltd
- Industry
- Eligibility
- 12 Years to 16 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 9
- States / cities
- San Diego, California • Ormond Beach, Florida • Tampa, Florida + 6 more
- Conditions
- Plaque Psoriasis
- Interventions
- Enstilar, Vehicle, Otezla
- Drug
- Lead sponsor
- L.H. Kircik, M.D.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 28 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 4
- States / cities
- Sacramento, California • Louisville, Kentucky • Rockville, Maryland + 1 more
- Conditions
- Psoriasis
- Interventions
- vehicle foam, calcipotriene, calcipotriene + clobetasol propionate
- Drug
- Lead sponsor
- Leon Kircik, M.D.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Louisville, Kentucky
- Conditions
- Nail Psoriasis
- Interventions
- Enstilar Foam
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Carcinoma, Squamous Cell
- Interventions
- 5-fluorouracil, Calcipotriene
- Drug
- Lead sponsor
- Melissa Pugliano-Mauro
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2027
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Psoriasis Vulgaris
- Interventions
- Calcipotriol plus hydrocortisone (LEO 80190)
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 6
- States / cities
- Hot Springs, Arkansas • Little Rock, Arkansas • Ormond Beach, Florida + 3 more
- Conditions
- Scalp Psoriasis
- Interventions
- Betamethasone Scalp Suspension 0.064%;0.0005%, Taclonex®, Placebo topical suspension
- Drug
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 485 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Charlotte, North Carolina
- Conditions
- Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ
- Interventions
- Combination cream of 5-fluorouracil and calcipotriene, 5-fluorouracil cream
- Drug
- Lead sponsor
- Boston University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Plaque Psoriasis
- Interventions
- LEXETTE 0.05% Topical Foam, Sorilux 0.005 % Topical Foam, Vehicle Foam
- Drug · Other
- Lead sponsor
- Skin Sciences, PLLC
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Louisville, Kentucky
- Conditions
- Psoriasis
- Interventions
- Enstilar
- Drug
- Lead sponsor
- Psoriasis Treatment Center of Central New Jersey
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- East Windsor, New Jersey
- Conditions
- Psoriasis
- Interventions
- Calcipotriene/betamethasone gel and ointment
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Actinic Keratoses
- Interventions
- Calcipotriene 0.005% Foam, Efudex 5% Topical Cream
- Drug
- Lead sponsor
- Tulane University
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Psoriasis Vulgaris
- Interventions
- LEO 80185 gel
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 125 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 8
- States / cities
- San Diego, California • Tampa, Florida • Indianapolis, Indiana + 5 more
- Conditions
- Scalp Psoriasis
- Interventions
- Calcipotriene and betamethasone suspension, Taclonex, Placebo
- Drug
- Lead sponsor
- Tolmar Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 699 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 34
- States / cities
- Hot Springs, Arkansas • Fremont, California • Los Angeles, California + 28 more
- Conditions
- Psoriasis Vulgaris
- Interventions
- MC2-01 Cream, CAL/BDP combination
- Drug
- Lead sponsor
- MC2 Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Sweetwater, Florida
- Conditions
- Psoriasis
- Interventions
- Enstilar 0.005%-0.064% Topical Foam
- Drug
- Lead sponsor
- Psoriasis Treatment Center of Central New Jersey
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- East Windsor, New Jersey
- Conditions
- Plaque Psoriasis
- Interventions
- M518101, placebo, Dovonex
- Drug
- Lead sponsor
- Maruho Co., Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 294 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2011
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Fresno, California + 28 more
- Conditions
- Psoriasis Vulgaris
- Interventions
- Calcipotriene plus betamethasone dipropionate ointment
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 8
- States / cities
- Fremont, California • San Diego, California • Maitland, Florida + 5 more